278 related articles for article (PubMed ID: 26373278)
1. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.
Mazor T; Pankov A; Johnson BE; Hong C; Hamilton EG; Bell RJA; Smirnov IV; Reis GF; Phillips JJ; Barnes MJ; Idbaih A; Alentorn A; Kloezeman JJ; Lamfers MLM; Bollen AW; Taylor BS; Molinaro AM; Olshen AB; Chang SM; Song JS; Costello JF
Cancer Cell; 2015 Sep; 28(3):307-317. PubMed ID: 26373278
[TBL] [Abstract][Full Text] [Related]
2.
Fomchenko EI; Erson-Omay EZ; Zhao A; Bindra RS; Huttner A; Fulbright RK; Moliterno J
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371348
[TBL] [Abstract][Full Text] [Related]
3. The Amazing and Deadly Glioma Race.
Ramaswamy V; Taylor MD
Cancer Cell; 2015 Sep; 28(3):275-7. PubMed ID: 26373273
[TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
6. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.
Mathios D; Hwang T; Xia Y; Phallen J; Rui Y; See AP; Maxwell R; Belcaid Z; Casaos J; Burger PC; McDonald KL; Gallia GL; Cope L; Kai M; Brem H; Pardoll DM; Ha P; Green JJ; Velculescu VE; Bettegowda C; Park CK; Lim M
Int J Cancer; 2019 Dec; 145(12):3425-3435. PubMed ID: 31373686
[TBL] [Abstract][Full Text] [Related]
8. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response.
Johnson KC; Anderson KJ; Courtois ET; Gujar AD; Barthel FP; Varn FS; Luo D; Seignon M; Yi E; Kim H; Estecio MRH; Zhao D; Tang M; Navin NE; Maurya R; Ngan CY; Verburg N; de Witt Hamer PC; Bulsara K; Samuels ML; Das S; Robson P; Verhaak RGW
Nat Genet; 2021 Oct; 53(10):1456-1468. PubMed ID: 34594038
[TBL] [Abstract][Full Text] [Related]
9. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation level of promoter region of activating transcription factor 5 in glioma.
Hua XM; Wang J; Qian DM; Song JY; Chen H; Zhu XL; Zhou R; Zhao YD; Zhou XZ; Li L; Zhang L; Song XX; Wang B
J Zhejiang Univ Sci B; 2015 Sep; 16(9):757-62. PubMed ID: 26365117
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples.
Shahi MH; Zazpe I; Afzal M; Sinha S; Rebhun RB; Meléndez B; Rey JA; Castresana JS
Tumour Biol; 2015 Apr; 36(4):2383-91. PubMed ID: 25416442
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states.
Chaligne R; Gaiti F; Silverbush D; Schiffman JS; Weisman HR; Kluegel L; Gritsch S; Deochand SD; Gonzalez Castro LN; Richman AR; Klughammer J; Biancalani T; Muus C; Sheridan C; Alonso A; Izzo F; Park J; Rozenblatt-Rosen O; Regev A; Suvà ML; Landau DA
Nat Genet; 2021 Oct; 53(10):1469-1479. PubMed ID: 34594037
[TBL] [Abstract][Full Text] [Related]
15. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
Núñez FJ; Mendez FM; Kadiyala P; Alghamri MS; Savelieff MG; Garcia-Fabiani MB; Haase S; Koschmann C; Calinescu AA; Kamran N; Saxena M; Patel R; Carney S; Guo MZ; Edwards M; Ljungman M; Qin T; Sartor MA; Tagett R; Venneti S; Brosnan-Cashman J; Meeker A; Gorbunova V; Zhao L; Kremer DM; Zhang L; Lyssiotis CA; Jones L; Herting CJ; Ross JL; Hambardzumyan D; Hervey-Jumper S; Figueroa ME; Lowenstein PR; Castro MG
Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760578
[TBL] [Abstract][Full Text] [Related]
16. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
J Dabrowski M; Wojtas B
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.
Wang H; Feng Y; Bao Z; Jiang C; Yan W; Wang Y; Zhang C; Liu Y; Zhang Q; Zhang W; Jiang C
Oncol Rep; 2013 Nov; 30(5):2089-96. PubMed ID: 24002581
[TBL] [Abstract][Full Text] [Related]
19. DNA hypomethylation of CD133 promoter is associated with recurrent glioma.
Sun B; Wan Z; Shen J; Ni L; Chen J; Cui M; Ni H; Shi W; Shi J
Oncol Rep; 2016 Aug; 36(2):1062-8. PubMed ID: 27374817
[TBL] [Abstract][Full Text] [Related]
20. CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.
Liu DM; Wang HJ; Han B; Meng XQ; Chen MH; Yang DB; Sun Y; Li YL; Jiang CL
CNS Neurosci Ther; 2016 Jun; 22(6):518-24. PubMed ID: 27012733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]